查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1288895

全球細胞和基因治療製造服務市場研究報告 - 行業分析、規模、佔有率、成長、趨勢和2023年至2030年預測

Global Cell & Gene Therapy Manufacturing Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 250 Pages | 商品交期: 最快1-2個工作天內

價格

細胞和基因治療製造服務包括細胞和基因治療產品的全面無縫製造和質量測試服務。該服務提供者説明生物技術和製藥公司以及研究小組促進轉化和臨床發現，並營造協作和創新的環境。細胞治療生產服務包括同種異體、自體和病毒載體，而基因治療生產服務包括非病毒載體、寡核苷酸和病毒載體。細胞和基因治療生產服務提供靈活和開創性的工具，以簡化工作流程、創新、可擴充性、定製、一致性、可重複性、降低風險，並在製造過程的每一步進行導航。

市場動態：

癌症和慢性病的高患病率，製藥和生物研究支出的增加以及公司和CDMO之間合作的增加等因素主要推動了全球細胞和基因治療製造服務市場的增長。細胞和基因療法為治療和緩解危及生命的疾病提供了潛在的希望。製藥公司正在大力投資開發新藥和療法。製藥公司通常將其研究CDMO或CRO外包，以專注於核心活動。此外，製藥公司發現高品質和高效率的研發具有挑戰性。外包是最好的方法。然而，與細胞和基因治療製造有關的高運營成本可能會在一定程度上抑制市場增長。

該研究報告包括波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於獲得一個清晰的行業結構圖，並在全球範圍內評估競爭吸引力。此外，這些工具還對全球細胞和基因治療製造服務市場的每個細分市場進行了全面評估。細胞和基因治療製造服務行業的成長和趨勢為這項研究提供了一個全面的方法。

區域分析：

本節涵蓋了區域前景，強調了北美、歐洲、亞太、拉美、中東和非洲的細胞和基因治療製造服務市場的當前和未來需求。此外，該報告重點關注所有突出地區的個別應用部門的需求、估計和預測。

該研究報告還涵蓋了市場中主要參與者的全面概況和對全球競爭格局的深入看法。細胞和基因治療製造服務市場的主要參與者包括Lonza（瑞士）、Catalent Inc.（美國）、Thermo Fisher Scientific Inc.（美國）、Charles River Laboratories（美國）、WuXi AppTec（中國）、Merck KGaA（德國）、Takara Bio Inc.(日本）、牛津生物醫學公司（英國）、細胞和基因治療中心（英國）、Genezen（美國）、FUJIFILM控股公司（日本）、尼康公司（日本）、The Discovery Labs LLC（美國）、RoslinCT（蘇格蘭）、JRS Pharma（德國）、FinVector（芬蘭）、ABL Inc.(美國）、Resilience（美國）、BioCentriq（美國）、Porton Advanced Solutions（中國）、Andelyn Biosciences（美國）、Forge Biologics（美國）、Vibalogics（美國）、Anemocyte Srl（義大利）、ElevateBio（美國） 本節由競爭格局的整體觀點組成，包括各種戰略發展，如關鍵的合併和收購、未來能力、夥伴關係、財務概況、合作、新產品開發、新產品推出和其他發展。

  • 如果你有任何定製要求，請寫信給我們。我們的研究團隊可以根據您的需要提供定製報告。

目錄

第1章：前言

  • 報告描述
    • 目的
    • 目標受眾
    • 獨特的銷售主張（USP）和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法

第二章：執行摘要

  • 市場的亮點
  • 全球市場簡介

第三章：細胞和基因治療製造服務- 行業分析

  • 簡介- 市場動態
  • 市場驅動力
  • 市場限制因素
  • 機會
  • 行業趨勢
  • 波特的五力分析
  • 市場吸引力分析
    • 按類型
    • 按適應症分類
    • 按應用分類：按應用分類
    • 按終端用戶
    • 按地區

第四章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商名單
    • 關鍵原料的價格趨勢
  • 潛在買家名單
  • 行銷管道
    • 直接行銷
    • 間接行銷
    • 行銷管道的發展趨勢

第五章：Covid-19爆發的影響分析

第六章：全球細胞和基因治療製造服務市場分析：按類型分類

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 細胞治療市場：按地區分類
  • 基因治療市場：按地區分類

第7章：全球細胞和基因治療製造服務市場分析：按適應症分類

  • 按適應症概述
  • 歷史和預測數據
  • 按適應症分析
  • 腫瘤疾病市場：按地區分類
  • 心血管疾病市場：按地區分類
  • 骨科疾病市場：按地區分類
  • 眼科疾病市場：按地區分類
  • 中樞神經系統疾病市場：按地區分類
  • 傳染性疾病市場：按地區分類
  • 其他市場：按地區分類

第八章：全球細胞和基因治療製造服務市場分析：按應用分類

  • 概述：按應用分類
  • 歷史和預測數據
  • 分析：按應用分類
  • 臨床製造市場：按地區分類
  • 商業製造市場：按地區分類

第九章：全球細胞和基因治療製造服務市場分析：按終端用戶分類

  • 按終端用戶概述
  • 歷史和預測數據
  • 按終端用戶分析
  • 製藥和生物技術公司市場：按地區分類
  • 學術和研究機構市場：按地區分類
  • 其他終端用戶市場：按地區分類

第十章：全球細胞和基因治療製造服務市場分析：按地域分類

  • 區域展望
  • 簡介
  • 北美洲
    • 概述、歷史和預測數據
    • 北美洲：按細分市場分類
    • 北美洲：按國家分類
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 概述、歷史和預測數據
    • 按部門分類的歐洲
    • 歐洲：按國家分類
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 歐洲其他地區
  • 亞太地區
    • 概述、歷史和預測數據
    • 亞太地區按細分市場分類
    • 亞太地區：按國家分類
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞
    • 亞太其他地區
  • 拉美地區
    • 概述、歷史和預測數據
    • 按部門分類的拉美地區
    • 拉丁美洲：按國家分類
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 拉美其他地區
  • 中東和非洲
    • 概述、歷史和預測數據
    • 中東和非洲，按細分市場分類
    • 中東和非洲：按國家分類
    • 沙烏地阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 南非
    • 其他中東和非洲國家

第11章：細胞和基因治療製造服務企業的競爭格局

  • 細胞和基因治療製造服務市場競爭
  • 夥伴關係/合作/協議
  • 合併和收購
  • 新產品發布
  • 其他方面的發展

第十二章：公司簡介

  • 公司佔有率分析
  • 市場集中度
  • Lonza (Switzerland)
    • 公司概況
    • 產品
    • 近期發展情況
  • Catalent Inc. (US)
    • 公司概況
    • 產品
    • 近期發展
  • Thermo Fisher Scientific Inc. (US)
    • 公司概況
    • 產品
    • 近期發展
  • Charles River Laboratories (US)
    • 公司概況
    • 產品
    • 近期發展
  • WuXi AppTec (China)
    • 公司概況
    • 產品
    • 近期發展
  • Merck KGaA (Germany)
    • 公司概況
    • 產品
    • 近期發展
  • Takara Bio Inc. (Japan)
    • 公司概況
    • 產品
    • 近期發展
  • Oxford Biomedica (UK)
    • 公司概況
    • 產品
    • 近期發展
  • Cell and Gene Therapy Catapult (UK)
    • 公司概況
    • 產品
    • 近期發展
  • Genezen (US)
    • 公司概況
    • 產品
    • 近期發展
  • FUJIFILM Holdings Corporation (Japan)
    • 公司概況
    • 產品
    • 近期發展
  • Nikon Corporation (Japan)
    • 公司概況
    • 產品
    • 近期發展
  • The Discovery Labs LLC (US)
    • 公司概況
    • 產品
    • 近期發展
  • RoslinCT (Scotland)
    • 公司概況
    • 產品
    • 近期發展
  • JRS Pharma (Germany)
    • 公司概況
    • 產品
    • 近期發展
  • FinVector (Finland)
    • 公司概況
    • 產品
    • 近期發展
  • ABL Inc. (US)
    • 公司概況
    • 產品
    • 近期發展
  • Resilience (US)
    • 公司概況
    • 產品
    • 近期發展
  • BioCentriq (US)
    • 公司概況
    • 產品
    • 近期發展
  • Porton Advanced Solutions (China)
    • 公司概況
    • 產品
    • 近期發展
  • Andelyn Biosciences (US)
    • 公司概況
    • 產品
    • 近期發展
  • Forge Biologics (US)
    • 公司概況
    • 產品
    • 近期發展
  • Vibalogics (US)
    • 公司概況
    • 產品
    • 近期發展
  • Anemocyte Srl (Italy)
    • 公司概況
    • 產品
    • 近期發展
  • ElevateBio (US)
    • 公司概況
    • 產品
    • 近期發展情況

注意- 在公司簡介中，財務細節和最近的發展情況取決於可用性，可能不包括私人公司在內。

Product Code: VMR11215654

Cell & gene therapy manufacturing services include comprehensive and seamless manufacturing and quality-testing services for cellular and gene therapy products. The service provider helps biotechnology & pharmaceutical companies and research groups boost translational and clinical discoveries and foster an environment of collaboration and innovation. Cell therapy manufacturing services include allogeneic, autologous, and viral vectors, while gene therapy manufacturing services non-viral vectors, oligonucleotides, and viral vectors. Cell & gene therapy manufacturing services provide flexible and pioneering tools to simplify workflow, innovation, scalability, customization, consistency, reproducibility, reducing risk, and navigate at every step of the manufacturing process.

Market Dynamics:

Factors such as the high prevalence of cancer and chronic diseases, increasing spending in pharmaceutical & biological research, and increasing collaboration among companies and CDMOs are primarily driving the growth of the global cell & gene therapy manufacturing services market. Cell and gene therapies offer potential promise to treat and relieve life-threatening diseases. Pharmaceutical companies are massively investing in the development of new drugs and therapies. Pharmaceutical companies are more usually outsource their research CDMOs or CROs to focus on core activities. Moreover, Pharmaceutical companies find it challenging to do R&D with high quality and efficiency. Outsourcing stands out as the best approach to them. However, the high operational costs concerned with cell & gene therapy manufacturing are likely to restrain market growth to some extent.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell & gene therapy manufacturing services. The growth and trends of cell & gene therapy manufacturing services industry provide a holistic approach to this study.

Market Segmentation:

This section of the cell & gene therapy manufacturing services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Cell Therapy (Allogeneic, Autologous, Viral Vector)
  • Gene Therapy (Non-viral Vector, Viral Vector)

By Indication

  • Oncology Diseases
  • Cardiovascular Diseases
  • Orthopedic Diseases
  • Ophthalmology Diseases
  • Central Nervous System Disorders
  • Infectious Diseases
  • Other

By Application

  • Clinical Manufacturing
  • Commercial Manufacturing

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Other End User

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Cell & Gene Therapy Manufacturing Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cell & gene therapy manufacturing services market include Lonza (Switzerland), Catalent Inc. (US), Thermo Fisher Scientific Inc. (US), Charles River Laboratories (US), WuXi AppTec (China), Merck KGaA (Germany), Takara Bio Inc. (Japan), Oxford Biomedica (UK), Cell and Gene Therapy Catapult (UK), Genezen (US), FUJIFILM Holdings Corporation (Japan), Nikon Corporation (Japan), The Discovery Labs LLC (US), RoslinCT (Scotland), JRS Pharma (Germany), FinVector (Finland), ABL Inc. (US), Resilience (US), BioCentriq (US), Porton Advanced Solutions (China), Andelyn Biosciences (US), Forge Biologics (US), Vibalogics (US), Anemocyte Srl (Italy), ElevateBio (US) This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

  • In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CELL & GENE THERAPY MANUFACTURING SERVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Type
    • 3.7.2 By Indication
    • 3.7.3 By Application
    • 3.7.4 By End User
    • 3.7.5 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Cell Therapy Market by Regions
  • 6.5 Gene Therapy Market by Regions

7 . GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET ANALYSIS BY INDICATION

  • 7.1 Overview by Indication
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Indication
  • 7.4 Oncology Diseases Market by Regions
  • 7.5 Cardiovascular Diseases Market by Regions
  • 7.6 Orthopedic Diseases Market by Regions
  • 7.7 Ophthalmology Diseases Market by Regions
  • 7.8 Central Nervous System Disorders Market by Regions
  • 7.9 Infectious Diseases Market by Regions
  • 7.10. Other Market by Regions

8 . GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Clinical Manufacturing Market by Regions
  • 8.5 Commercial Manufacturing Market by Regions

9 . GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET ANALYSIS BY END USER

  • 9.1 Overview by End User
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End User
  • 9.4 Pharmaceutical & Biotechnology Companies Market by Regions
  • 9.5 Academic & Research Institutes Market by Regions
  • 9.6 Other End User Market by Regions

10 . GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America
    • 10.3.1. Overview, Historic and Forecast Data
    • 10.3.2. North America By Segment
    • 10.3.3. North America By Country
    • 10.3.4. United State
    • 10.3.5. Canada
    • 10.3.6. Mexico
  • 10.4. Europe
    • 10.4.1. Overview, Historic and Forecast Data
    • 10.4.2. Europe by Segment
    • 10.4.3. Europe by Country
    • 10.4.4. United Kingdom
    • 10.4.5. France
    • 10.4.6. Germany
    • 10.4.7. Italy
    • 10.4.8. Russia
    • 10.4.9. Rest Of Europe
  • 10.5. Asia Pacific
    • 10.5.1. Overview, Historic and Forecast Data
    • 10.5.2. Asia Pacific by Segment
    • 10.5.3. Asia Pacific by Country
    • 10.5.4. China
    • 10.5.5. India
    • 10.5.6. Japan
    • 10.5.7. South Korea
    • 10.5.8. Australia
    • 10.5.9. Rest Of Asia Pacific
  • 10.6. Latin America
    • 10.6.1. Overview, Historic and Forecast Data
    • 10.6.2. Latin America by Segment
    • 10.6.3. Latin America by Country
    • 10.6.4. Brazil
    • 10.6.5. Argentina
    • 10.6.6. Peru
    • 10.6.7. Chile
    • 10.6.8. Rest of Latin America
  • 10.7. Middle East & Africa
    • 10.7.1. Overview, Historic and Forecast Data
    • 10.7.2. Middle East & Africa by Segment
    • 10.7.3. Middle East & Africa by Country
    • 10.7.4. Saudi Arabia
    • 10.7.5. UAE
    • 10.7.6. Israel
    • 10.7.7. South Africa
    • 10.7.8. Rest Of Middle East And Africa

11 . COMPETITIVE LANDSCAPE OF THE CELL & GENE THERAPY MANUFACTURING SERVICES COMPANIES

  • 11.1. Cell & Gene Therapy Manufacturing Services Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF CELL & GENE THERAPY MANUFACTURING SERVICES INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Lonza (Switzerland)
    • 12.3.1. Company Overview
    • 12.3.2. Financials
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Catalent Inc. (US)
    • 12.4.1. Company Overview
    • 12.4.2. Financials
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Thermo Fisher Scientific Inc. (US)
    • 12.5.1. Company Overview
    • 12.5.2. Financials
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Charles River Laboratories (US)
    • 12.6.1. Company Overview
    • 12.6.2. Financials
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. WuXi AppTec (China)
    • 12.7.1. Company Overview
    • 12.7.2. Financials
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Merck KGaA (Germany)
    • 12.8.1. Company Overview
    • 12.8.2. Financials
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Takara Bio Inc. (Japan)
    • 12.9.1. Company Overview
    • 12.9.2. Financials
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Oxford Biomedica (UK)
    • 12.10.1. Company Overview
    • 12.10.2. Financials
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. Cell and Gene Therapy Catapult (UK)
    • 12.11.1. Company Overview
    • 12.11.2. Financials
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. Genezen (US)
    • 12.12.1. Company Overview
    • 12.12.2. Financials
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. FUJIFILM Holdings Corporation (Japan)
    • 12.13.1. Company Overview
    • 12.13.2. Financials
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. Nikon Corporation (Japan)
    • 12.14.1. Company Overview
    • 12.14.2. Financials
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. The Discovery Labs LLC (US)
    • 12.15.1. Company Overview
    • 12.15.2. Financials
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. RoslinCT (Scotland)
    • 12.16.1. Company Overview
    • 12.16.2. Financials
    • 12.16.3. Products
    • 12.16.4. Recent Developments
  • 12.17. JRS Pharma (Germany)
    • 12.17.1. Company Overview
    • 12.17.2. Financials
    • 12.17.3. Products
    • 12.17.4. Recent Developments
  • 12.18. FinVector (Finland)
    • 12.18.1. Company Overview
    • 12.18.2. Financials
    • 12.18.3. Products
    • 12.18.4. Recent Developments
  • 12.19. ABL Inc. (US)
    • 12.19.1. Company Overview
    • 12.19.2. Financials
    • 12.19.3. Products
    • 12.19.4. Recent Developments
  • 12.20. Resilience (US)
    • 12.20.1. Company Overview
    • 12.20.2. Financials
    • 12.20.3. Products
    • 12.20.4. Recent Developments
  • 12.21. BioCentriq (US)
    • 12.21.1. Company Overview
    • 12.21.2. Financials
    • 12.21.3. Products
    • 12.21.4. Recent Developments
  • 12.22. Porton Advanced Solutions (China)
    • 12.22.1. Company Overview
    • 12.22.2. Financials
    • 12.22.3. Products
    • 12.22.4. Recent Developments
  • 12.23. Andelyn Biosciences (US)
    • 12.23.1. Company Overview
    • 12.23.2. Financials
    • 12.23.3. Products
    • 12.23.4. Recent Developments
  • 12.24. Forge Biologics (US)
    • 12.24.1. Company Overview
    • 12.24.2. Financials
    • 12.24.3. Products
    • 12.24.4. Recent Developments
  • 12.25. Vibalogics (US)
    • 12.25.1. Company Overview
    • 12.25.2. Financials
    • 12.25.3. Products
    • 12.25.4. Recent Developments
  • 12.26. Anemocyte Srl (Italy)
    • 12.26.1. Company Overview
    • 12.26.2. Financials
    • 12.26.3. Products
    • 12.26.4. Recent Developments
  • 12.27. ElevateBio (US)
    • 12.27.1. Company Overview
    • 12.27.2. Financials
    • 12.27.3. Products
    • 12.27.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Cell Therapy Market by Geography (USD MN)
  • Gene Therapy Market by Geography (USD MN)
  • Analysis Market by Indication (USD MN)
  • Oncology Diseases Market by Geography (USD MN)
  • Cardiovascular Diseases Market by Geography (USD MN)
  • Orthopedic Diseases Market by Geography (USD MN)
  • Ophthalmology Diseases Market by Geography (USD MN)
  • Central Nervous System Disorders Market by Geography (USD MN)
  • Infectious Diseases Market by Geography (USD MN)
  • Other Market by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Clinical Manufacturing Market by Geography (USD MN)
  • Commercial Manufacturing Market by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Pharmaceutical & Biotechnology Companies Market by Geography (USD MN)
  • Academic & Research Institutes Market by Geography (USD MN)
  • Other End User Market by Geography (USD MN)
  • Global Cell & Gene Therapy Manufacturing Services Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Cell & Gene Therapy Manufacturing Services Report
  • Market Research Process
  • Market Research Methodology
  • Global Cell & Gene Therapy Manufacturing Services Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Cell Therapy Market by Geography (USD MN)
  • Gene Therapy Market by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Oncology Diseases Market by Geography (USD MN)
  • Cardiovascular Diseases Market by Geography (USD MN)
  • Orthopedic Diseases Market by Geography (USD MN)
  • Ophthalmology Diseases Market by Geography (USD MN)
  • Central Nervous System Disorders Market by Geography (USD MN)
  • Infectious Diseases Market by Geography (USD MN)
  • Other Market by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Clinical Manufacturing Market by Geography (USD MN)
  • Commercial Manufacturing Market by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Pharmaceutical & Biotechnology Companies Market by Geography (USD MN)
  • Academic & Research Institutes Market by Geography (USD MN)
  • Other End User Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.